...
首页> 外文期刊>Journal of molecular cell biology >The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells
【24h】

The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells

机译:抑癌药ING1b是雄激素受体的新型协同抑制剂,可诱导前列腺癌细胞衰老

获取原文
           

摘要

The androgen receptor (AR) signaling is critical for prostate cancer (PCa) progression to the castration-resistant stage with poor clinical outcome. Altered function of AR-interacting factors may contribute to castration-resistant PCa (CRPCa). Inhibitor of growth 1 (ING1) is a tumor suppressor that regulates various cellular processes including cell proliferation. Interestingly, ING1 expression is upregulated in senescent primary human prostate cells; however, its role in AR signaling in PCa was unknown. Using a proteomic approach by surface-enhanced laser desorption ionization-mass spectrometry (SELDI-MS) combined with immunological techniques, we provide here evidence that ING1b interacts in vivo with the AR. The interaction was confirmed by co-immunoprecipitation, in vitro GST-pull-down, and quantitative intracellular colocalization analyses. Functionally, ING1b inhibits AR-responsive promoters and endogenous key AR target genes in the human PCa LNCaP cells. Conversely, ING1b knockout (KO) mouse embryonic fibroblasts (MEFs) exhibit enhanced AR activity, suggesting that the interaction with ING1b represses the AR-mediated transcription. Also, data suggest that ING1b expression is downregulated in CRPCa cells compared with androgen-dependent LNCaP cells. Interestingly, its ectopic expression induces cellular senescence and reduces cell migration in both androgen-dependent and CRPCa cells. Intriguingly, ING1b can also inhibit androgen-induced growth in LNCaP cells in a similar manner as AR antagonists. Moreover, ING1b upregulates different cell cycle inhibitors including p27 KIP1 , which is a novel target for ING1b. Taken together, our findings reveal a novel corepressor function of ING1b on various AR functions, thereby inhibiting PCa cell growth.
机译:雄激素受体(AR)信号对于前列腺癌(PCa)进展为去势抵抗期且临床预后较差的疾病至关重要。 AR相互作用因子功能的改变可能有助于抵抗去势的PCa(CRPCa)。生长抑制剂1(ING1)是一种肿瘤抑制因子,可调节各种细胞过程,包括细胞增殖。有趣的是,ING1表达在衰老的原代人前列腺细胞中表达上调。然而,其在PCa中AR信号传导中的作用尚不清楚。使用蛋白质组学方法通过表面增强激光解吸电离质谱(SELDI-MS)结合免疫技术,在这里我们提供ING1b在体内与AR相互作用的证据。通过共免疫沉淀,体外GST下拉和定量细胞内共定位分析证实了相互作用。在功能上,ING1b抑制人PCa LNCaP细胞中的AR反应性启动子和内源性关键AR靶基因。相反,ING1b基因敲除(KO)小鼠胚胎成纤维细胞(MEF)表现出增强的AR活性,表明与ING1b的相互作用抑制了AR介导的转录。此外,数据表明与雄激素依赖性LNCaP细胞相比,CRPCa细胞中的ING1b表达下调。有趣的是,它的异位表达可诱导细胞衰老并减少雄激素依赖性和CRPCa细胞中的细胞迁移。有趣的是,ING1b还可以以与AR拮抗剂相似的方式抑制LNCaP细胞中雄激素诱导的生长。此外,ING1b上调了不同的细胞周期抑制剂,包括p27 KIP1,这是ING1b的新靶标。综上所述,我们的发现揭示了ING1b在各种AR功能上具有新颖的共抑制功能,从而抑制了PCa细胞的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号